Structural basis for partial agonism and allosteric modulation of the 5HT3AR

被引:0
|
作者
Felt, Kevin C. [1 ]
Stauffer, Madeleine [1 ]
Salas-Estrada, Leslie [2 ]
Filizola, Marta [3 ]
Chakrapani, Sudha [4 ]
机构
[1] Case Western Reserve Univ, Dept Physiol & Biophys, Cleveland, OH USA
[2] Icahn Sch Med Mt Sinai, New York, NY USA
[3] Icahn Sch Med Mt Sinai, Dept Pharmacol Sci, New York, NY USA
[4] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH USA
关键词
D O I
暂无
中图分类号
Q6 [生物物理学];
学科分类号
071011 ;
摘要
2207-Pos
引用
收藏
页码:396A / 396A
页数:1
相关论文
共 50 条
  • [41] Structural basis for the allosteric modulation of rhodopsin by nanobody binding to its extracellular domain
    Wu, Arum
    Salom, David
    Hong, John D.
    Tworak, Aleksander
    Watanabe, Kohei
    Pardon, Els
    Steyaert, Jan
    Kandori, Hideki
    Katayama, Kota
    Kiser, Philip D.
    Palczewski, Krzysztof
    NATURE COMMUNICATIONS, 2023, 14 (01)
  • [42] Structural basis for modulation of a G-protein-coupled receptor by allosteric drugs
    Ron O. Dror
    Hillary F. Green
    Celine Valant
    David W. Borhani
    James R. Valcourt
    Albert C. Pan
    Daniel H. Arlow
    Meritxell Canals
    J. Robert Lane
    Raphaël Rahmani
    Jonathan B. Baell
    Patrick M. Sexton
    Arthur Christopoulos
    David E. Shaw
    Nature, 2013, 503 : 295 - 299
  • [43] Molecular basis of partial agonism: Orientation of indoleamine ligands in the binding pocket of the human serotonin 5-HT2A receptor determines relative efficacy
    Ebersole, BJ
    Visiers, I
    Weinstein, H
    Sealfon, SC
    MOLECULAR PHARMACOLOGY, 2003, 63 (01) : 36 - 43
  • [44] Structural Basis of the Negative Allosteric Modulation of 5-BDBD at Human P2X4 Receptors
    Bidula, Stefan
    Bin Nadzirin, Izzuddin
    Cominetti, Marco
    Hickey, Harry
    Cullum, Sean A.
    Searcey, Mark
    Schmid, Ralf
    Fountain, Samuel J.
    MOLECULAR PHARMACOLOGY, 2022, 101 (01) : 33 - 44
  • [45] Allosteric modulation of the human 5-HT7A receptor by lipidic amphipathic compounds
    Alberts, GL
    Chio, CL
    Im, WB
    MOLECULAR PHARMACOLOGY, 2001, 60 (06) : 1349 - 1355
  • [46] Evolutionary action and structural basis of the allosteric switch controlling β2AR functional selectivity
    Schonegge, Anne-Marie
    Gallion, Jonathan
    Picard, Louis-Philippe
    Wilkins, Angela D.
    Le Gouill, Christian
    Audet, Martin
    Stallaert, Wayne
    Lohse, Martin J.
    Kimmel, Marek
    Lichtarge, Olivier
    Bouvier, Michel
    NATURE COMMUNICATIONS, 2017, 8
  • [47] Evolutionary action and structural basis of the allosteric switch controlling β2AR functional selectivity
    Anne-Marie Schönegge
    Jonathan Gallion
    Louis-Philippe Picard
    Angela D. Wilkins
    Christian Le Gouill
    Martin Audet
    Wayne Stallaert
    Martin J. Lohse
    Marek Kimmel
    Olivier Lichtarge
    Michel Bouvier
    Nature Communications, 8
  • [48] Biased allosteric agonism and modulation of metabotropic glutamate receptor 5: Implications for optimizing preclinical neuroscience drug discovery
    Sengmany, Kathy
    Singh, Junaid
    Stewart, Gregory D.
    Conn, P. Jeffrey
    Christopoulos, Arthur
    Gregory, Karen J.
    NEUROPHARMACOLOGY, 2017, 115 : 60 - 72
  • [49] Structural Basis for Allosteric Modulation of Class B G Protein-Coupled Receptors
    Wootten, Denise
    Miller, Laurence J.
    ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, VOL 60, 2020, 60 : 89 - 107
  • [50] Structural Basis for Negative Allosteric Modulation of GluN2A-Containing NMDA Receptors
    Yi, Feng
    Mou, Tung-Chung
    Dorsett, Katherine N.
    Volkmann, Robert A.
    Menniti, Frank S.
    Sprang, Stephen R.
    Hansen, Kasper B.
    NEURON, 2016, 91 (06) : 1316 - 1329